CADD-Solis Medication Safety Software, Administrator CD, Version 3.1, REF 21-2194-0301-01. Pro...

FDA Device Recall #Z-0166-2015 — Class II — September 29, 2014

Recall Summary

Recall Number Z-0166-2015
Classification Class II — Moderate risk
Date Initiated September 29, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Smiths Medical ASD, Inc.
Location Saint Paul, MN
Product Type Devices
Quantity 24

Product Description

CADD-Solis Medication Safety Software, Administrator CD, Version 3.1, REF 21-2194-0301-01. Product Usage: The CADD-Solis Medication Safety Software- Administrator allows use of a computer to create therapy-based protocol libraries to be used with the CADD-Solis VIP Ambulatory Infusion Pump, CADD-Solis Ambulatory Infusion Pump, or CADD-Prizm PCSII Ambulatory Infusion Pump (software revision H or higher). The CADD-Solis Medication Safety Software- Point of Care allows use of a computer to send therapy-based protocols developed by the CADD-Solis Medication Safety Software.- Administrator to the CADD -Solis Ambulatory Infusion Pump and CADD-Prizm PCS I I Ambulatory Infusion Pump (software revision H or higher).

Reason for Recall

Smiths Medical has identified an issue with a single batch (Lot Number 2752712) of CADD"-Solis Medication Safety Software Administrator 3.1 CDs. CADD"-Solis Medication Safety Software Administrator 3.1 CDs were sent with the CADD"-Solis Medication Safety Software Point of Care 3.1 software loaded on them.

Distribution Pattern

US Nationwide Distribution in the state of AK, CA, CO, CT, GA, MI, MN, NH, NC, SC, TX, VA, WI.

Lot / Code Information

Lot Number 2752712

Other Recalls from Smiths Medical ASD, Inc.

Recall # Classification Product Date
Z-1667-2025 Class I CADD-Solis HPCA Ambulatory Infusion Pump; Mode... Apr 10, 2025
Z-1681-2025 Class I CADD-Solis Infusion Pump Models: 1) PUMP KIT,... Apr 10, 2025
Z-1668-2025 Class I CADD-Solis VIP Ambulatory Infusion Pump; Mode... Apr 10, 2025
Z-1662-2025 Class I CADD Solis HSPCA Pump Apr 10, 2025
Z-1682-2025 Class I CADD Solis VIP Ambulatory Infusion Pump Models:... Apr 10, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.